# Clinical Cases: Gram-Positive Cocci

## Case 1: MRSA Skin and Soft Tissue Infection

### Presentation
A 28-year-old otherwise healthy man presents to urgent care with a painful "boil" on his right thigh that has been worsening over 5 days. He first noticed a small red bump that he thought was a spider bite. He is an amateur wrestler and practices 3-4 times per week. He has no significant medical history and takes no medications.

Physical examination reveals a 4 cm indurated, erythematous, fluctuant mass on the anterior right thigh with central purulent drainage. There is surrounding cellulitis extending 2 cm beyond the abscess border. He is afebrile and hemodynamically stable. No inguinal lymphadenopathy is appreciated.

Gram stain of the purulent drainage shows gram-positive cocci in clusters.

### Clinical Image
![Gram-positive cocci in clusters](image_01.png)
*Gram stain demonstrating gram-positive cocci in grape-like clusters - characteristic appearance of Staphylococcus aureus.*

**Image Source**: Lecture image - staphylococcal morphology

### Questions

1. **What is the most likely causative organism, and what epidemiological factors in this patient's history support this diagnosis?**

2. **The culture result confirms methicillin-resistant Staphylococcus aureus (MRSA). What is the genetic and molecular basis of methicillin resistance?**

3. **What is the most important treatment intervention for this patient's abscess?**

4. **A toxin called Panton-Valentine leukocidin (PVL) is commonly associated with community-acquired MRSA strains. What is its mechanism and clinical significance?**

### Answers

1. **Most likely organism and epidemiology**: **Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA)** is the most likely causative organism. Supporting epidemiological factors include:
   - **Contact sport participation**: Wrestlers have significantly elevated MRSA rates due to skin-to-skin contact, shared equipment, and skin abrasions
   - **Healthy young adult**: CA-MRSA typically affects healthy individuals without healthcare exposure, unlike healthcare-associated MRSA (HA-MRSA)
   - **Skin abscess presentation**: CA-MRSA classically presents as skin and soft tissue infections, particularly abscesses, furuncles, and carbuncles
   - **"Spider bite" history**: Patients frequently initially attribute CA-MRSA skin infections to spider bites

   The Gram stain showing gram-positive cocci in grape-like clusters is pathognomonic for staphylococci.

2. **Genetic basis of methicillin resistance**:
   - **mecA gene**: MRSA carries the mecA gene located on the staphylococcal cassette chromosome mec (SCCmec)
   - **PBP2a production**: mecA encodes **penicillin-binding protein 2a (PBP2a)**, an altered transpeptidase enzyme
   - **Reduced β-lactam affinity**: PBP2a has very low affinity for all β-lactam antibiotics (penicillins, cephalosporins, carbapenems), allowing cell wall synthesis to continue despite antibiotic presence
   - **Cross-resistance**: Methicillin resistance confers resistance to ALL β-lactam antibiotics except for the newer agents ceftaroline and ceftobiprole, which have affinity for PBP2a
   - **Laboratory detection**: mecA can be detected by cefoxitin disk diffusion (cefoxitin is a better inducer of mecA expression than oxacillin) or by PCR for the mecA gene

3. **Most important treatment intervention**: **Incision and drainage (I&D)** is the cornerstone of treatment for skin abscesses and is often curative alone for uncomplicated abscesses <5 cm without surrounding cellulitis.

   For this patient with a 4 cm abscess AND surrounding cellulitis, treatment should include:
   - **Incision and drainage**: Essential - antibiotics without I&D often fail
   - **Antibiotics covering MRSA**: Options for outpatient management include:
     - Trimethoprim-sulfamethoxazole (TMP-SMX) - most commonly used
     - Doxycycline
     - Clindamycin (check local resistance patterns; inducible resistance may occur)
   - Cultures should be sent to confirm susceptibility
   - Duration: 5-10 days depending on response

4. **Panton-Valentine leukocidin (PVL)**:
   - **Mechanism**: PVL is a bicomponent pore-forming toxin consisting of two secreted proteins (LukS-PV and LukF-PV) that oligomerize on neutrophil membranes to form pores
   - **Target specificity**: PVL specifically targets and destroys neutrophils and macrophages
   - **Clinical significance**:
     - Associated with 77% of CA-MRSA strains (especially USA300 clone) vs. <5% of HA-MRSA
     - Correlates with severe necrotizing skin infections
     - Associated with necrotizing pneumonia (often post-influenza)
     - Contributes to recurrent furunculosis
   - **Pathogenic contribution**: By destroying the primary phagocytic defense against S. aureus, PVL promotes bacterial survival and enhances tissue destruction

---

## Case 2: Streptococcal Pharyngitis and Complications

### Presentation
A 7-year-old girl is brought to the pediatrician by her mother with a 2-day history of sore throat, fever, and refusal to eat. She attends school where several classmates have recently been sick with sore throats. She has no cough, runny nose, or hoarseness.

Physical examination reveals temperature 38.8°C, pharyngeal erythema with tonsillar exudates, and tender bilateral anterior cervical lymphadenopathy. She has a fine, sandpaper-textured erythematous rash on her trunk with accentuation in the skin folds of her elbows (Pastia lines). Her tongue initially shows a white coating with prominent papillae, consistent with early "strawberry tongue."

A rapid streptococcal antigen test is positive.

### Clinical Image
![Streptococcal identification](image_05.png)
*Laboratory identification of streptococci including hemolysis patterns on blood agar - essential for differentiating streptococcal species.*

**Image Source**: Lecture image - streptococcal identification

### Questions

1. **What is the diagnosis, and what virulence factor is responsible for the rash?**

2. **Why is antibiotic treatment of Group A streptococcal pharyngitis important beyond symptomatic relief?**

3. **Three weeks later, the patient returns with periorbital edema, dark urine, and blood pressure 130/85 mmHg. What complication has developed?**

4. **What is the mechanism of this complication, and could it have been prevented with antibiotic treatment?**

### Answers

1. **Diagnosis and virulence factor**: The diagnosis is **scarlet fever** - Group A streptococcal (Streptococcus pyogenes) pharyngitis with an associated toxin-mediated rash.

   The rash is caused by **streptococcal pyrogenic exotoxins (Spe proteins, particularly SpeA, SpeB, or SpeC)**. These exotoxins are:
   - **Superantigens**: Similar mechanism to staphylococcal TSST-1
   - **Erythrogenic toxins**: Cause the characteristic erythematous rash
   - The rash is fine and sandpaper-textured, sparing the palms and soles
   - **Pastia lines**: Linear accentuation in skin folds from capillary fragility
   - **Strawberry tongue**: Initially white-coated with prominent papillae, later becoming red ("raspberry tongue")

   Note: Scarlet fever is not more severe than strep pharyngitis alone - it simply indicates the strain produces erythrogenic toxin and the patient lacks preexisting antibodies to that toxin.

2. **Importance of antibiotic treatment**:

   **Primary reasons for treating GAS pharyngitis**:
   - **Prevention of acute rheumatic fever (ARF)**: The most important reason. Antibiotic treatment within 9 days of symptom onset prevents ARF
   - **Faster symptom resolution**: Antibiotics shorten illness duration by 1-2 days
   - **Reduced transmission**: Treatment reduces contagiousness, allowing earlier return to school
   - **Prevention of suppurative complications**: Peritonsillar abscess, cervical lymphadenitis, mastoiditis

   **Treatment of choice**: Penicillin V orally for 10 days or amoxicillin once daily for 10 days. No penicillin-resistant GAS strains have ever been documented. For penicillin-allergic patients: azithromycin, cephalosporins (if not anaphylactic allergy), or clindamycin.

3. **Complication**: **Post-streptococcal glomerulonephritis (PSGN)**.

   Clinical features:
   - Periorbital edema (fluid retention)
   - Dark/cola-colored urine (hematuria)
   - Hypertension
   - Onset 1-3 weeks after GAS pharyngitis or 3-6 weeks after skin infection

   Laboratory findings would show:
   - Urinalysis: Hematuria with RBC casts, proteinuria
   - Low serum C3 complement (consumed during immune complex deposition)
   - Elevated ASO titer (evidence of recent strep infection)
   - Mild elevation of creatinine

4. **Mechanism and prevention**:

   **Mechanism (immune complex-mediated disease)**:
   - PSGN is caused by deposition of immune complexes (streptococcal antigen-antibody complexes) in glomerular capillary walls
   - This activates complement (explaining low C3) and triggers inflammatory response
   - Results in proliferative glomerulonephritis with neutrophil infiltration
   - Only certain "nephritogenic" strains of GAS cause PSGN (M types 1, 2, 4, 12, 25, 49)

   **Could antibiotics have prevented this?**:
   - **NO** - Unlike acute rheumatic fever, PSGN is NOT prevented by antibiotic treatment
   - By the time pharyngitis symptoms appear, immune complex formation has already begun
   - The immune response causing glomerular injury is already underway before diagnosis
   - Treatment is supportive (salt and fluid restriction, antihypertensives, diuretics)

   **Prognosis**: Excellent in children - >95% recover completely. Adults may have more persistent abnormalities.